Dateline City:
KENILWORTH, N.J.
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
announced the successful completion of the tender offer for all of the
outstanding shares of common stock of Cubist Pharmaceuticals, Inc.
(NASDAQ: CBST) at a purchase price of $102.00 per share.
Language:
English
Contact:
MerckMedia:Lainie Keller, 908-236-5036orSteve Cragle, 908-740-1801orInvestor:Joe Romanelli, 908-740-1986orJustin Holko, 908-740-1879
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more